mRNA |
CUDC-101 |
GDSC1000 |
pan-cancer |
AAC |
0.015 |
0.6 |
mRNA |
GSK4112 |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
PD-0325901 |
CCLE |
pan-cancer |
AAC |
-0.021 |
0.6 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.6 |
mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.6 |
mRNA |
BYL-719 |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.6 |
mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.6 |
mRNA |
CGP-082996 |
GDSC1000 |
pan-cancer |
AAC |
-0.026 |
0.6 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.6 |
mRNA |
KU-0063794 |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.6 |